EUCOPE's #LifeScienceLectures - Episode Two "Defining High Unmet Medical Need (HUMN)"
EHA 2024 | Whose needs exactly? Unmet medical need in the EU pharmaceutical legislation
Orphan Drug Development | Episode 06 - USFDA vs EMA : Orphan Drug Designation | Regulatory Affairs
The EMA perspective on drug approval process in the era of precision medicine
Webinar on revision of the pharmaceutical legislation
Unmet Therapeutic Needs: What Are They and Can We Find the Fixes?
Medical Device Regulation
Public System Demo Q3/2024
EMA & EATRIS present: Scientific Advice for Advanced Therapy Medicinal Products: What & When to Ask
FDA-EMA Parallel Scientific Advice (PSA) Program
EU ATMPs Quality Regulation
Are current investments in medical research focusing on unmet health needs?
EU HTA Regulation Insights: Expert Strategies for Success
EMA workshop on haemoglobinopathies
Required and Enhanced RWHAP Unmet Need Estimates and Analyses: Exploring the Possibilities
Microbiome Products as Drugs: EU and US Definitions
IMT Use Case: How to apply and benefit from an ODD
Webinar Pilot to provide Scientific Advice to manufactures on certain high risk Medical Devices
Information session on the pilot for expert panels' advice for orphan medical devices
2021 T1D Workshop- EMA perspective | Peter Mol